Fairmount Funds Management LLC
SYREFairmount Funds Management LLC serves as director, 10 percent owner: at Spyre Therapeutics, Inc. (SYRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Fairmount Funds Management LLC's Insider Trading at Spyre Therapeutics, Inc. (SYRE)
Buys
0 · $0.00
Sells
1 · $399.66M
Total Shares Bought
0
Total Shares Sold
4,684,781
Fairmount Funds Management LLC's Insider Trading at Oruka Therapeutics, Inc. (ORKA)
Buys
0 · $0.00
Sells
1 · $300.01M
Total Shares Bought
0
Total Shares Sold
3,553,410
Fairmount Funds Management LLC's Insider Trading at Cogent Biosciences, Inc. (COGT)
Buys
0 · $0.00
Sells
1 · $242.62M
Total Shares Bought
0
Total Shares Sold
7,000,000
Fairmount Funds Management LLC's Insider Trading at Viridian Therapeutics, Inc. (VRDN)
Buys
5 · $80.00M
Sells
0 · $0.00
Total Shares Bought
4,587,191
Total Shares Sold
0
Fairmount Funds Management LLC's Insider Trading at Zenas BioPharma, Inc. (ZBIO)
Buys
1 · $3.00M
Sells
0 · $0.00
Total Shares Bought
150,000
Total Shares Sold
0
Fairmount Funds Management LLC's Insider Trading at Dianthus Therapeutics, Inc. (DNTH)
Buys
4 · $1.40M
Sells
0 · $0.00
Total Shares Bought
108,924
Total Shares Sold
0
Related Insiders
Arjun Agarwal
officer: Senior Vice President, Finance
Scott L Burrows
officer: Chief Financial Officer
Cameron Turtle
director, officer: Chief Executive Officer
Sheldon Sloan
officer: Chief Medical Officer
Laura Lee Sandler
officer: Chief Operating Officer
HENDERSON MICHAEL THOMAS
director
Lawrence Otto Klein
director, officer: Chief Executive Officer
Paul T Quinlan
officer: General Counsel